Search

Search results

399 results found

Briakinumab.

Lima, Xinaida Taligare, Katrina Abuabara, Alexandra Boer Kimball, and Hermenio Cavalcante Lima. 2009. “Briakinumab.”. Expert Opinion on Biological Therapy 9 (8): 1107-13.

Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.

Kimball, Alexa Boer, Michael H Gold, Beth Zib, Mark W Davis, and Clobetasol Propionate Emulsion Formulation Foam Phase Clinical Study Group III. 2008. “Clobetasol Propionate Emulsion Formulation Foam 0.05%: Review of Phase II Open-Label and Phase III Randomized Controlled Trials in Steroid-Responsive Dermatoses in Adults and Adolescents.”. Journal of the American Academy of Dermatology 59 (3): 448-54, 454.e1.